A study published in the Journal of American Medicine in 2023 found that the use of GLP-1 agonists for weight loss was associated with an increased risk of pancreatitis, stomach paralysis, and bowel obstruction
Now, oral versions like semaglutide are removing barriers for many patients by offering these benefits in pill form
8cf and Supplementary Fig
Recommended injection sites include the abdomen at least two inches from the navel, the front or outer thigh, and the back of the upper arm
Participants reported drinking less, experienced fewer effects of alcohol when they did drink it, and decreased odds of binge drinking, co-author Alexandra DiFeliceantonio, an assistant professor at Fralin Biomedical Research Institute, said in the news release
Starting elderly patients at 2.5 mg remains appropriate, but extending each dose tier to 6 to 8 weeks rather than 4 weeks improves tolerability